Glycopolymeric nanoparticles transported by activated platelets protect ischemic myocardium by alleviating PANoptosis through targeting macrophage Dectin‐1
BMEMat · 29.07.2026
DOI: 10.1002/bmm2.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMEMat, online erschienen am 29.07.2026. Verfasst von Guanye Yu und 13 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Myocardial ischemia–reperfusion (IR) injury poses a great threat to human health. In recent years, targeted modulation of immune and thrombotic responses has emerged as a promising therapeutic strategy. Here, we develop a glycopolymeric nanoparticle with fucose and sialic acid segments ( NP‐SF ), with enhanced affinity to Dectin‐1, a critical immunoregulatory target, thus suppressing inflammatory responses of macrophages. Additionally, as the mimic of P‐selectin glycoprotein ligand‐1 (PSGL‐1), NP‐SF leverages activated platelets for targeted delivery to ischemic myocardium and suppresses platelet aggregate formation. In murine IR models, NP‐SF significantly reduces inflammation and infarcted size, subsequently improving cardiac function. NP‐SF is enriched in injured myocardium, where it is retained by macrophages and attenuates pro‐inflammatory macrophage infiltration. Mechanistically, NP‐SF downregulates spleen tyrosine kinase (SYK) signaling, markedly inhibiting PANoptosis by suppressing NLR family CARD domain containing 5 (NLRC5) and PANoptosome complex formation. This cascade attenuates pro‐inflammatory cytokine release. In conclusion, NP‐SF leverages platelet hitchhiking and Dectin‐1 interactions as a dual‐targeted therapeutic agent to resolve macrophage‐driven PANoptosis, offering a translatable strategy for IR injury.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Yu, G., Yang, N., Zhang, Y., Peng, L., Li, Y., Chao, Y., Miao, Q., Qi, H., Zhuang, J., Jian, W., Li, B., Peng, W., Chen, J., & Gong, S. (2026). Glycopolymeric nanoparticles transported by activated platelets protect ischemic myocardium by alleviating PANoptosis through targeting macrophage Dectin‐1. BMEMat. https://doi.org/10.1002/bmm2.70109
Vancouver
Yu G, Yang N, Zhang Y, Peng L, Li Y, Chao Y, et al. Glycopolymeric nanoparticles transported by activated platelets protect ischemic myocardium by alleviating PANoptosis through targeting macrophage Dectin‐1. BMEMat. 2026. doi:10.1002/bmm2.70109
BibTeX
@article{Yu2026,
author = {Yu, Guanye and Yang, Na and Zhang, Yan and Peng, Lingxin and Li, Yi and Chao, Yue and Miao, Qinfang and Qi, Haikun and Zhuang, Jianhui and Jian, Weixia and Li, Bingyu and Peng, Wenhui and Chen, Jinghua and Gong, Shiyu},
title = {Glycopolymeric nanoparticles transported by activated platelets protect ischemic myocardium by alleviating PANoptosis through targeting macrophage Dectin‐1},
journal = {BMEMat},
year = {2026},
doi = {10.1002/bmm2.70109}
}
EUVIMED